BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2023 8:26:32 AM | Browse: 559 | Download: 1690
Publication Name World Journal of Clinical Cases
Manuscript ID 83820
Country China
Received
2023-03-17 02:25
Peer-Review Started
2023-03-17 02:28
First Decision by Editorial Office Director
2023-06-19 07:16
Return for Revision
2023-06-19 07:16
Revised
2023-07-02 15:10
Publication Fee Transferred
Editorial Processing by Scientific Editor
2023-08-01 02:31
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2023-08-01 07:54
Articles in Press
2023-08-01 07:54
Edit the Manuscript by Language Editor
2023-07-31 08:08
Typeset the Manuscript
2023-08-16 01:28
Publish the Manuscript Online
2023-08-25 08:26
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Hematology
Manuscript Type Case Control Study
Article Title Reduction rate of monoclonal protein as a useful prognostic factor in standard-risk group of newly diagnosed multiple myeloma Reduction rate of M protein as a useful prognostic factor in standard-risk group of newly diagnosed multiple myeloma
Manuscript Source Unsolicited Manuscript
All Author List Min Liu and Jun-Yu Zhang
ORCID
Author(s) ORCID Number
Min Liu http://orcid.org/0000-0002-8540-5095
Jun-Yu Zhang http://orcid.org/0000-0002-1013-8172
Funding Agency and Grant Number
Corresponding Author Jun-Yu Zhang, MM, Chief Doctor, Department of Hematology, Lishui Municipal Central Hospital, No. 289 Kuocang Road, Lishui 323000, Zhejiang Province, China. zhangjunyu815@163.com
Key Words Multiple myeloma; Monoclonal protein; Progression-free survival; Chemotherapy
Core Tip Multiple myeloma (MM) is a common hematologic malignancy that originates from a malignant clone of plasma cells. Solitary plasmacytoma, history of diabetes, and platelet count are considered as prognostic factors for MM. But some patients are still associated with much worse outcomes without any prognostic predictors. This study aimed to observe the reduction rate of monoclonal protein after the first and fourth chemotherapy cycles, which is considered as a new prognostic factor for progression-free survival in standard-risk group of newly diagnosed MM patients.
Publish Date 2023-08-25 08:26
Citation Liu M, Zhang JY. Reduction rate of monoclonal protein as a useful prognostic factor in standard-risk group of newly diagnosed multiple myeloma. World J Clin Cases 2023; 11(24): 5643-5652
URL https://www.wjgnet.com/2307-8960/full/v11/i24/5643.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i24.5643
Full Article (PDF) WJCC-11-5643-with-cover.pdf
Full Article (Word) WJCC-11-5643.docx